[go: up one dir, main page]

MX2010011193A - Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. - Google Patents

Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.

Info

Publication number
MX2010011193A
MX2010011193A MX2010011193A MX2010011193A MX2010011193A MX 2010011193 A MX2010011193 A MX 2010011193A MX 2010011193 A MX2010011193 A MX 2010011193A MX 2010011193 A MX2010011193 A MX 2010011193A MX 2010011193 A MX2010011193 A MX 2010011193A
Authority
MX
Mexico
Prior art keywords
prevention
pharmaceutical composition
liquid pharmaceutical
pain treatment
treatment
Prior art date
Application number
MX2010011193A
Other languages
English (en)
Inventor
Armenta Maria Elena Garcia
Murillo Josefina Santos
Ochoa Victor Guillermo Alvarez
Original Assignee
World Trade Imp Exp Wtie Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by World Trade Imp Exp Wtie Ag filed Critical World Trade Imp Exp Wtie Ag
Priority to MX2010011193A priority Critical patent/MX2010011193A/es
Priority to PCT/IB2011/002373 priority patent/WO2012049550A1/es
Priority to ARP110103770A priority patent/AR083393A1/es
Publication of MX2010011193A publication Critical patent/MX2010011193A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/407—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with other heterocyclic ring systems, e.g. ketorolac, physostigmine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Rheumatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La presente invención se refiere a una composición farmacéutica líquida, en solución, formulada para ser administrada por vía oral en forma de gotas, que comprende la combinación sinérgica de ketorolaco y tramadol, además de excipientes farmacéuticamente aceptables, útil en la prevención y el tratamiento del dolor de intensidad moderada a severa manifestado en pacientes pediátricos sin presentar efectos colaterales adversos.
MX2010011193A 2010-10-12 2010-10-12 Composicion farmaceutica liquida para el tratamiento y prevencion del dolor. MX2010011193A (es)

Priority Applications (3)

Application Number Priority Date Filing Date Title
MX2010011193A MX2010011193A (es) 2010-10-12 2010-10-12 Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.
PCT/IB2011/002373 WO2012049550A1 (es) 2010-10-12 2011-10-10 Composicíon farmacéutica liquida para el tratamiento y prevención del dolor
ARP110103770A AR083393A1 (es) 2010-10-12 2011-10-12 Composicion farmaceutica liquida para el tratamiento y prevencion del dolor

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MX2010011193A MX2010011193A (es) 2010-10-12 2010-10-12 Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.

Publications (1)

Publication Number Publication Date
MX2010011193A true MX2010011193A (es) 2012-04-18

Family

ID=45937950

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2010011193A MX2010011193A (es) 2010-10-12 2010-10-12 Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.

Country Status (3)

Country Link
AR (1) AR083393A1 (es)
MX (1) MX2010011193A (es)
WO (1) WO2012049550A1 (es)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019143234A1 (es) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2014005152A (es) * 2014-04-29 2015-10-28 Liomont S A De C V Lab Composicion farmaceutica para el tratamiento de alopatias relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol.
WO2019122982A1 (en) 2017-12-21 2019-06-27 Grünenthal GmbH Pharmaceutical combination in a bilayer tablet form comprising ketorolac tromethamine and tramadol hydrochloride, and its use in pain treatment
GR1009629B (el) * 2018-02-20 2019-10-25 Laboserve Φαρμακευτικη Βιομηχανια Α.Ε. Ποσιμα διαλυματα που περιλαμβανουν τραμαδολη

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA02010828A (es) * 2002-11-04 2004-07-16 Leopoldo Espinosa Abdala Composicion farmaceutica en capsulas que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
MXPA03012048A (es) * 2003-12-19 2005-06-23 Victor Guillermo Alvarez Ochoa Composiciones farmaceuticas en solucion inyectable que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.
MX2007003948A (es) * 2007-04-02 2009-02-25 World Trade Imp Export Wtie Ag Composicion farmaceutica en forma de tableta sublingual que comprende un antiinflamatorio no esteroideo y un analgesico opiaceo para el manejo del dolor.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019143234A1 (es) 2018-01-22 2019-07-25 AMÉZCUA AMÉZCUA, Federico Combinación farmacéutica sinérgica del enantiómero activo s-ketorolaco trometamina y clorhidrato de tramadol

Also Published As

Publication number Publication date
AR083393A1 (es) 2013-02-21
WO2012049550A1 (es) 2012-04-19

Similar Documents

Publication Publication Date Title
EA201270221A1 (ru) Лечение болезни крона с применением лаквинимода
WO2008131056A3 (en) Sustained release monoeximic formulations of opioid and nonopioid analgesics
HK1221646A1 (zh) 高剂量普利多匹定用於治疗亨廷顿舞蹈症的用途
NZ700881A (en) Compositions and methods comprising celecoxib or related compounds and dextromethorphan
WO2012098562A3 (en) Liquid oral compositions of lanthanum salts
ES2916649T1 (es) Composiciones y usos para el tratamiento de la esclerosis múltiple
WO2012007159A3 (en) Novel gastro-retentive dosage forms
EA201491285A1 (ru) Улучшенные композиции и способы доставки омепразола и ацетилсалициловой кислоты
MY152279A (en) Immediate release pharmaceutical compositions comprising oxycodone and naloxone
NZ714963A (en) Compositions and methods for treating anemia
MY173215A (en) Acetylcysteine compositions and methods of use thereof
PH12014500386A1 (en) Combination treatment for hepatitis c
PH12014502447A1 (en) Use of high dose laquinimod for treating multiple sclerosis
UA106636C2 (uk) Морфолінотіазоли як позитивні алостеричні модулятори альфа 7
MX2012000488A (es) Terapia de combinacion para el tratamiento de la diabetes.
NZ715686A (en) Pharmaceutical for oral delivery comprising mgbg and methods of treating disease
MX2015001917A (es) Composiciones farmaceuticas de memantina.
WO2014071168A3 (en) Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients
ZA202000028B (en) Use of vibegron to treat overactive bladder
WO2012053013A3 (en) Pharmaceutical compositions of anti-acne agents
WO2008008882A3 (en) Glucocorticoid receptor modulator and methods of use
MX2010011193A (es) Composicion farmaceutica liquida para el tratamiento y prevencion del dolor.
MX2013003523A (es) Composicion farmaceutica de dosis baja.
MX2016008027A (es) Uso de laquinimod para retrasar la evolucion de la enfermedad de huntington.
MX2010013484A (es) Formulaciones en dosis unitaria de ketorolaco para administración intra-nasal.

Legal Events

Date Code Title Description
GD Licence granted
GD Licence granted
GB Transfer or assignment

Owner name: PPTM INTERNATIONAL, S.A.R.L.

GD Licence granted
GD Licence granted
FA Abandonment or withdrawal